Trial intelligence / Profile preview

Magnesium with intrathecal lidocaine to reduce transient neurologic syndrome after same-day surgery

2012-004538-40Phase 3Completed

Sponsor
Hospital General Universitario Ciudad Real
Start
Nov 2012
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium and lidocaine in Postoperative Neurologic Syndrome (2 arms), sponsored by Hospital General Universitario Ciudad Real. Primary endpoint: Postoperative transient neurologic syndrome rate. Started Nov 2012; status: completed.

02

Drugs

magnesiumlidocaine
03

Conditions

Postoperative Neurologic Syndrome

Beyond the preview

Go deeper on 2012-004538-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004538-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call